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Abstract
Background Medication for elderly patients is often
complex and problematic. Several criteria for classifying
inappropriate prescribing exist. In 2010, the Swedish
National Board of Health and Welfare published the doc-
ument ‘‘Indicators of appropriate drug therapy in the
elderly’’ as a guideline for improving prescribing for the
elderly.
Objective The aim of this study was to assess trends in
the prescription of inappropriate drug therapy in the elderly
in Sweden from 2006 to 2013 using national quality indi-
cators for drug treatment.
Methods Individual-based data on dispensed prescription
drugs for the entire Swedish population aged C65 years
during eight 3-month periods from 2006 to 2013 were
accumulated. The data were extracted from the Swedish
Prescribed Drug Register. Eight drug-specific quality
indicators were monitored.
Results For the entire population studied (n = 1,828,283
in 2013), six of the eight indicators showed an improve-
ment according to the guidelines; the remaining two indi-
cators (drugs with anticholinergic effects and excessive
polypharmacy) remained relatively unchanged. For the
subgroup aged 65–74 years, three indicators showed an
improvement, four indicators remained relatively unchan-
ged (e.g. propiomazine, and oxazepam) and one showed an
undesirable trend (anticholinergic drugs) according to
guidelines. For the older group (aged C75 years), all
indicators except excessive polypharmacy showed
improvement.
Conclusion According to the quality indicators used, the
extent of inappropriate drug therapy in the elderly
decreased from 2006 to 2013 in Sweden. Thus, prescribers
appear to be more likely to change their prescribing pat-
terns for the elderly than previously assumed.
Key Points
According to the quality indicators used, the extent
of inappropriate drug therapy in the elderly
decreased from 2006 to 2013 in Sweden.
Prescribers appear to be more likely to change their
prescribing patterns for the elderly than previously
assumed.
1 Background
Medication for older people (those aged C65 years) is
often perceived as complex and problematic, and various
efforts have been made to improve drug therapy for the
elderly, primarily by trying to avoid drugs deemed to be
‘inappropriate’ [1].
Several documents listing criteria for classifying inap-
propriate prescriptions have been offered. Almost all of
these focus on the use of specific drugs by individual
elderly patients, e.g. Beers’ criteria [2], the Improving
Prescribing in the Elderly Tool (IPET) [3], the Screening
Tool of Older persons’ Potentially inappropriate Prescrip-
tions (STOPP) [4], McLeod’s criteria [5], and the Medi-
cation Appropriateness Index (MAI) [6]. Some studies
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have used a combination of several of the more well-
known criteria [7].
The widely recognized MAI and Beers’ criteria were
published in the early 1990s. The MAI measures the
overall prescription quality in ten areas, without specifying
which drugs are to be avoided [6]. Originally, Beers’ cri-
teria included a list of drugs to be avoided only in the
elderly nursing home population [2] but they were then
modified to include community-dwelling elderly [8] and
were later updated [9].
In 2003, the Swedish National Board of Health and
Welfare issued a proposal based on international develop-
ments in the field [2, 5, 8–12] presenting indicators that
could be used to evaluate the quality of drug use by the
elderly in Sweden [13]. The intention was that the indi-
cators should be applied under a variety of circumstances
in order to improve the drug therapy of elderly patients: by
supporting the prescription of drugs to the elderly, when
monitoring prescribing patterns, and in national monitoring
and epidemiological studies. The indicators also enabled
investigation of the relationships between drug prescription
processes, outcomes and costs over time.
In 2009, a proposal for an updated, expanded version of
the quality indicators was presented and in 2010, ‘‘Indi-
cators of appropriate drug therapy in the elderly’’ was
published [14] (Table 1). Two groups of quality indicators
were provided in the document: drug-specific and diagno-
sis-specific. Some of these indicators are suitable for use in
the analysis of registers of dispensed drugs in large popu-
lations. It is important to underline that the drug-specific
indicators are defined in terms of the number of recipients
of the drug as a percentage of the entire elderly population
and are therefore primarily relevant on a population level
only. Furthermore, because of the increased sensitivity to
drugs with greater age, these indicators are most applicable
for the group aged over 75 years [14].
The establishment of the national Swedish Prescribed
Drug Register in 2005 enabled analysis of the utilization of
dispensed prescription drugs for the entire population [15].
The register provides individual data that can be used for
exploring and analyzing the quality of drug use in the
elderly for the whole of Sweden. These individual-based
data can also be applied in longitudinal studies of the
development of drug therapies for the elderly.
The Swedish Prescribed Drug Register has been used in
studies of drug treatment in the elderly since 2005 [16–18].
Unfortunately, over the years, the focus of these reports has
shifted from drug use among different age groups to
housing types, time periods and measuring methods.
Consequently, the results are not comparable over time.
Thus, no long-term trends concerning these indicators of
quality have been reported, and the need for an investiga-
tion in this area is apparent.
2 Objective
The aim of this study was to assess trends in the pre-
scription of inappropriate drug therapy in the elderly in
Sweden from 2006 to 2013 using national quality indica-
tors for drug treatment.
3 Methods
To assess changes in the extent of appropriate drug therapy
for older people in a national population, we employed a
list of drug-specific quality indicators from the publication
‘‘Indicators of appropriate drug therapy in the elderly’’
[14], obtained from the Swedish National Board of Health
and Welfare, and individual-based data on dispensed pre-
scription drugs in the entire Swedish population aged
C65 years over eight 3-month periods (January, February
and March) for the period 2006–2013. The data were
extracted from the Swedish Prescribed Drug Register [15].
With the assumption that the level of primary non-adher-
ence was unchanged for the drugs included in the indica-
tors during the study period, we used the data on dispensed
prescription drugs as proxy for changes in prescription
patterns during the study period.
The individual data relating to dispensed prescription
drugs were processed without the original personal iden-
tification numbers of the recipients; all data were anony-
mous. Instead, a unique temporary individual identifier,
specifying year of birth, was applied and the study popu-
lation was stratified by age (in 5-year groups). The results
are presented with respect to the number of individuals per
Table 1 Development of ‘‘Indicators of Appropriate Drug Therapy
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age group in the Swedish population during the corre-
sponding periods.
The number of individuals and the number of dispensed
prescription drugs per individual were recorded; a drug was
defined as a chemical entity or substance or combination of
substances from the fifth level in the Anatomical Thera-
peutic Chemical (ATC) classification system [19].
3.1 Indicators
We selected all the eight (out of 34) drug-specific indica-
tors from the publication ‘‘Indicators of appropriate drug
therapy in the elderly’’ that were suitable for application to
the register and did not require complementary information
from patients’ medical records. The selected indicators
belonged to three categories of drugs (A, B and C below)
that can be considered universally applicable to the elderly.
3.1.1 Category A: Drugs that Older People Should Avoid
Unless There are Special Reasons Not to Do So
The guidelines state that the number of elderly patients
who use these medications (as a percentage of the total
elderly population) should be as low as possible.
• Long-acting benzodiazepines: ATC code N05BA01
(diazepam), N05CD02 (nitrazepam), N05CD03
(flunitrazepam)
• Drugs with anticholinergic effects: ATC code A03AB
(glycopyrrolate), A03BA (e.g. atropine), A03BB (e.g.
butylscopolamine), A04AD (scopolamine), C01BA
(disopyramide), G04BD (e.g. oxybutynin), N02AG
(e.g. morphine), N04A (e.g. trihexyphenidyl), N05AA
(levomepromazine), N05AF03 (chlorprotixene),
N05AH02 (clozapine), N05BB01 (hydroxyzine),
N06AA (e.g. clomipramine), R06AA02 (dimenhydri-
nate), R06AB (e.g. chlorpheniramine), R06AD (e.g.
alimemazine), R06AX02 (cyproheptadine)
• Tramadol: ATC code N02AX02
• Propiomazine: ATC code N05CM06
3.1.2 Category B: Polypharmacy
The guidelines state that the number of elderly patients
receiving polypharmacy should be as low as possible.
• Excessive polypharmacy is defined as concomitant
treatment with ten or more drugs regularly or as
needed.
• Polypharmacy is also defined as concomitant treatment
with three or more psychotropic drugs [from one or
more ATC groups N05A (e.g. clozapine), N05B (e.g.
diazepam), N05C (e.g. zolpidem), N06 (e.g. fluoxe-
tine)] regularly or as needed.
3.1.3 Category C: Specific Psychotropic Drugs
The guidelines state that:
• Of all elderly patients treated with tranquilizers
(N05B), the proportion (percentage) who use oxazepam
(N05BA04) in preference to other alternatives in N05B
should be as high as possible.
• Of all elderly patients treated with hypnotics or
sedatives (N05C), the proportion who use zopiclone
(N05CF01) in preference to other alternatives in N05C
should be as high as possible.
3.2 Comparability of Data
Since ten or more dispensed drugs during a 3-month period is
the most widely used definition of excessive polypharmacy
[20–23], comparisons with other studies were possible. As a
rule, the filling of one prescription covers consumption for a
3-month period in Sweden. To achieve comparability
between indicators and over the years, we selected the same
periods for analyses of all the selected indicators.
3.3 Swedish Prescribed Drug Register
The Swedish Prescribed Drug Register [15] provides
records for the entire Swedish population and covers
approximately 82 % of all defined daily doses (DDDs) of
medications dispensed in Sweden. The register does not
include data on over-the-counter (OTC) medications
(13 %), in-hospital medications (4 %), or non-institutional
care medications (1 % of all DDDs distributed in Sweden).
The register is also not complete with regard to vaccines or
non-dose-dispensed drugs in nursing homes.
The Swedish Prescribed Drug Register is individual-
based and contains data on dispensed outpatient prescrip-
tions from all Swedish pharmacies from 1 July 2005. The
registration of dispensed drugs is mandatory in Sweden.
The following data were used in our study: the dispensed
drug (substance), date of dispensing, age, and unique
identifier (personal identification number) of the patient.
3.4 Study Population
The study population included all individuals aged
C65 years during eight 3-month periods (January, Febru-
ary and March) from 2006 to 2013. The number of par-
ticipants increased by 16.2 % from quarter (Q) 1 in 2006 to
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Q1 in 2013. The largest increase (39.8 %) occurred in the
group aged 65–69 years. The group aged 80–84 years
decreased by 4.4 %. The number of individuals in the
group aged 65–79 years increased by 22.6 %, and the
group aged C80 years increased by 1.9 % (Table 2).
The group aged C100 years was excluded from the
graphic representations of the eight indicators because of
the small numbers of individuals involved (n = 1,836,
representing 0.1 % of the study population in 2013).
Sums and frequencies were calculated using Microsoft
Excel, version 2010 (14.0.6126.5000) SP 1 MSO
(14.0.6129.5000), (Microsoft Corporation, Redmond, WA,
USA).
The study was approved by the Swedish Regional Eth-
ical Review Board in Linko¨ping.
4 Results
4.1 Drugs that Older People Should Avoid
4.1.1 Long-Acting Benzodiazepines
The number of elderly people for whom long-acting ben-
zodiazepines were dispensed, given as a percentage of the
total population aged C65 years, decreased from 3.5 % to
1.7 % (-52.2 %) in the period Q1 2006 to Q1 2013. The
proportion decreased consistently over the study period and
occurred in all age groups, with the greatest decrease seen
in the oldest group (95–99 years; -58.5 %; Fig. 1).
4.1.2 Drugs with Anticholinergic Effects
The number of elderly people for whom drugs with anti-
cholinergic effects were dispensed, given as a percentage
of the total elderly population, decreased marginally during
the study period, from 1.5 % to 1.4 % (-1.2).
There were decreases in the groups aged C80 years,
with the largest decrease in the oldest group (95–99 years;
-35.6 %). In the groups aged 65–69 years and
70–74 years, the proportion increased by 28.2 and 16.9 %,
respectively (Fig. 2).
4.1.3 Propiomazine
The number of elderly people for whom propiomazine was
dispensed, given as a percentage of the total elderly pop-
ulation, decreased from 2.7 % to 2.0 % (-24.4 %) during
the study period (Fig. 3).The decrease was consistent over
the study period. The proportion decreased in all age
groups, except for the group aged 65–69 years. The largest
decrease was seen in the oldest group (95–99 years;
-55.5 %).
4.1.4 Tramadol
The number of elderly people for whom tramadol was
dispensed, given as a percentage of the total elderly pop-
ulation, decreased from 3.9 % to 2.3 % (-41.1 %) during
the study period (Fig. 3).
The proportion decreased in all age groups, with the
largest decrease seen in the oldest group (95–99 years;
Table 2 The number of individuals in Sweden aged C65 years in 2006–2013, presented in 5-year age groups
Age group (years) 2006 2007 2008 2009 2010 2011 2012 2013
65–69 426,408 443,520 468,154 497,789 530,721 563,074 587,197 595,931
70–74 347,405 351,314 359,473 371,843 384,095 395,524 412,013 422,593
75–79 310,887 309,483 307,083 304,548 303,552 304,799 309,083 311,611
80–84 256,516 252,241 249,637 247,407 245,948 245,289 245,036 245,180
85–89 157,361 162,105 164,951 167,366 166,835 164,396 162,527 161,736
90–94 60,051 60,978 61,654 62,697 66,182 70,835 73,217 73,675
95–99 13,407 13,853 14,295 14,690 15,033 15,327 15,602 15,721
100? 1,375 1,433 1,502 1,591 1,648 1,715 1,803 1,836









































Fig. 1 The proportion of elderly individuals in Sweden (aged
C65 years), in 5-year age groups, for whom long-acting benzodiaze-
pines were dispensed over the period Q1 2006 to Q1 2013.
Q1 Quarter 1
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-65.3 %). The greatest reduction occurred between Q1
2012 and Q1 2013 (-19.3 %).
4.2 Polypharmacy
4.2.1 Excessive Polypharmacy
The number of elderly people receiving excessive poly-
pharmacy (ten or more concurrent prescription drugs dis-
pensed regularly or as required), given as a percentage of
the total elderly population, decreased marginally during
Q1 2006 to Q1 2013, from 10.1 % to 10.0 % (-1.2 %)
(Fig. 4). The difference between age groups was marginal.
4.2.2 Three or More Concurrent Psychotropic Drugs
The number of elderly people for whom three or more
concurrent psychotropic drugs were dispensed, given as a
percentage of the total elderly population, decreased from
3.5 % to 3.1 % (-11.0 %) during the study period (Fig. 4).
4.3 Individual Psychotropic Drugs
4.3.1 Oxazepam
The number of elderly patients for whom oxazepam was
dispensed, given as a percentage of the total elderly pop-
ulation receiving any tranquilizer, increased from 59.9 %
to 63.6 % (?6.2 %) over the period from Q1 2006 to Q1
2013 (Fig. 5). The largest increase was seen in the three
oldest groups (85–89 years, 90–94 years, and 95–99 years;
?11.8, ?12.4, and ?11.0 %, respectively).
4.3.2 Zopiclone
The number of elderly patients for whom zopiclone was
dispensed, given as a percentage of the total elderly pop-
ulation receiving any hypnotic or sedative, increased from
42.6 % to 53.9 % (?26.5 %) during the study period









































Fig. 2 The proportion of elderly individuals in Sweden (aged
C65 years), in 5-year age groups, for whom drugs with anticholin-





































Fig. 3 The proportion of elderly individuals in Sweden (aged
C65 years) for whom propiomazine and tramadol was dispensed




































Fig. 4 The proportion of elderly individuals in Sweden (aged
C65 years) for whom ten or more prescription drugs, or three or
more concurrent psychotropic drugs, were dispensed concurrently




































Fig. 5 The proportion of elderly individuals in Sweden (aged
C65 years) receiving tranquilizers for whom oxazepam was dis-
pensed, and the proportion of elderly individuals in Sweden (aged
C65 years) receiving hypnotics or sedatives for whom zopiclone was
dispensed, over the period Q1 2006 to Q1 2013. Q1 Quarter 1
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The largest increase was seen in the oldest groups (85–89
years, 90–94 years, and 95–99 years; ?32.8, ?34.4 and
?46.4 %, respectively).
5 Discussion
We found that the extent of inappropriate drug therapy for
the elderly (C65 years of age) improved, according to the
national guidelines for this age group, over the period
2006–2013 in Sweden. The positive trend was more pro-
nounced for those aged C75 years. Considering that the
medication requirements for older patients are commonly
described as increasingly complex and problematic, this
improvement was unexpected, and offers hope.
5.1 Long-Term Trends
The changes to the indicators were relatively constant
during the course of the study, particularly for the reduc-
tion in prescribing of long-acting benzodiazepines and the
increase in prescribing of zopiclone. Similarly, the absence
of change in the indicators for drugs with anticholinergic
effects and excessive polypharmacy was stable during the
whole period.
Our results displayed no clear link between the addition
of an indicator to the Swedish guidelines and changes to
prescribing patterns. For example, the indicator drugs with
anticholinergic effects has changed only marginally since it
was added to the guidelines in 2003, and the indicators
involving the use of tramadol, propiomazine, oxazepam
and zopiclone were already changing in the appropriate
direction before their introduction to the guidelines pro-
posal in 2009.
Our findings confirm that, for most of the indicators,
there is an ongoing long-term change in the patterns of
prescribing. It appears likely that the current debate on
drug therapy for the elderly has increased prescribers’
knowledge of inappropriate drugs and contributed to the
changes to quality indicators. However, it remains unre-
solved whether the observed trends were the result of
changes to the guidelines or whether the guidelines are
merely reflecting a change in prescribing practice that was
already occurring.
It also remains uncertain whether specific interventions
introduced with the aim of affecting the indicators have in
fact had any effect. In 2012, the Swedish government
offered to reward counties managing to decrease the indi-
cators of inappropriate drugs by 10 % in patients aged
C65 years. Two of the 21 counties succeeded at the time
[24] but the long-term effects of the intervention remain to
be seen.
Our results also suggest that some indicators may have
reached a level from which it is difficult to achieve any
further progress. This could be because there are few or no
alternative therapies available. It could also be the exis-
tence of other opposite treatment recommendations, e.g.
the Swedish Medical Product Agency state that the use of
drugs with anticholinergic effects are probably too low
today [25].
With respect to the indicator excessive polypharmacy,
while it may be possible to reduce or alter the use of one or
two specific drugs, it is difficult to reduce the overall level
of polypharmacy since there are many associated factors at
a population level, e.g. increasing life expectancy, devel-
opment of new therapies, increasing use of preventive
strategies, and medical guidelines [26].
5.2 Comparison with Other Studies
The Swedish Association of Local Authorities and Regions
and The National Board of Health and Welfare present the
report ‘‘Quality and Efficiency in Swedish Health Care’’
every year. Unfortunately, the indicators, monitored age
groups and methods of analysis have been altered through
the years, resulting in non-comparable data. Thus, there
have been no other reports of long-term trends in drug
prescribing for the elderly in Sweden. However, official
publications have discussed the difficulties associated with
achieving change and the perception of stagnation in the
process of reducing inappropriate medication to the elderly
[27].
Long-term trends in inappropriate prescribing in the
elderly have also been poorly investigated internationally
[28], and the available studies often describe non-compa-
rable sets of medications and use different measurement
tools to estimate the overall prevalence of inappropriate
prescribing [29, 30]. Nonetheless, studies have indicated, in
line with our results, a slight decrease in the use of
potentially inappropriate drugs by elderly patients [28, 31–
33].
Our findings that excessive polypharmacy has remained
at a constant level during the study period are not consis-
tent with results from official Swedish reports [34, 35].
Although the methods of measurement have changed over
the years and may have contributed to the decline, the
reports claim that the proportion of the elderly receiving
excessive polypharmacy has been reduced. In contrast, a
short-term study has indicated that the proportion of elderly
receiving excessive polypharmacy in Sweden increased
over the period from 2005 to 2008 [36]. The general trend
internationally also indicates an increasing prevalence of
polypharmacy [37–41]. However, an increasing prevalence
of polypharmacy does not necessarily imply increasing
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inappropriate prescribing among the elderly. Instead,
increased prevalence of polypharmacy can actually be
combined with reduced inappropriate prescribing [28].
5.3 Strengths and Weaknesses of the Study
The study does not cover all the national indicators of
appropriate drug therapies in the elderly. Analysis of other
drug- and diagnosis-specific indicators would have
required access to the patients’ medical records for gath-
ering complementary information records.
Since the indicators of quality chosen by the Swedish
National Board of Health and Welfare are ‘national stan-
dards’ in the study population, we have not addressed their
possible strengths and weaknesses compared with other
quality indicators, despite the availability of alternative
choices and the ongoing debate concerning the validity,
relevance, measurability, interpretability, and uniqueness
of different indicators.
As the study included all individuals in the population,
we were able to avoid known problems associated with
sampling, recall, interviews, and confidence levels. On the
other hand, using registered data on dispensed drugs as an
estimate of drug use could result in either over- or under-
estimation of actual drug use.
5.4 Unanswered Questions and Future Research
For patients aged 65–74 years, three of eight indicators
showed improvement over the 8-year period. During the
same period, the number of individuals in this age group
increased by 32 %, whereas the number of individuals aged
C75 years hardly increased at all. It remains to be seen
whether the overall positive trends in drug-specific quality
indicators for all elderly will continue when the increasing
number of individuals currently aged \75 years become
older.
During the study period, the prescribing of several drugs
included in the indicators declined and it is assumed that
other alternative medications have been prescribed instead.
The prescribing of alternative drugs and its clinical
implications for patients remains to be studied in detail,
e.g. the use of other opiates when the prescribing of
tramadol declined.
6 Conclusions
According to the quality indicators used, the extent of
inappropriate drug therapy in the elderly decreased from
2006 to 2013 in Sweden. This improvement was especially
evident in the oldest patients, although this group still had
the highest proportion of inappropriate drug use.
Overall, the results indicate that prescribers appear to be
more likely to change their prescribing patterns for the
elderly than previously assumed.
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